why choose us

First received: February 13, 2023

Clinical Trial: Impact of Non-Exudative Type 1 MNV on AMD Progression

Study Status: Completed

Recruit Status: RECRUITING

Condition: Age-Related Macular Degeneration

Study Type: OBSERVATIONAL


Official Title: The Impact of Non-Exudative Type 1 Macular Neovascularization (MNV) on Age-related Macular Degeneration (AMD) Progression

Brief Summary: The overall goal of the proposed research project is to provide evidence that a specific subtype of neovascularization that may develop in eyes with age-related macular degeneration (AMD) prevents vision loss.This concept challenges the current view that the development of neovascularizations in AMD represents a harmful event in general.Notably, before the era of anti-vascular endothelial growths factor (VEGF) therapy, destruction and surgical removal of neovascular membranes have been tested as treatment options…

Read more